return to small text site

 

US
Europe
US
Europe

press releases
press coverage
electronic press kit
Luveniq™
LX201

LX214
LX212
polymer technology
pipeline
other projects

uveitis
corneal transplantation
dry eye syndrome

age-related macular degeneration
mission
history
management
board of directors
investors

About
Ophthalmic Indications
Products &
Technologies

Partners
News & Media
Careers
Contact Us

 

 

Brett Skolnik
Chief Financial Officer
 

 

© 2008 Lux Biosciences, Inc. All rights reserved.                 Web Terms